OBJECTIVE: To compare the efficacy and cost-effectiveness of enoxaparin, a low-molecular-
weight heparin derivative, with that of low-dose warfarin in the prevention of deep-vein …

The costs of heparin and enoxaparin to prevent deep vein thrombosis (DVT) after total hip
replacement in the US treatment environment were compared. A decision model was used …

This prospective, double-blind trial was performed to determine whether 4 weeks'
prophylaxis with enoxaparin after total hip replacement (THR) is more effective in protecting …

A randomized, parallel-group, open-label clinical trial (the physicians, patients, and staff
were not blinded with regard to the regimen that had been used) was conducted, between …

Background: Enoxaparin sodium, a low-molecular-weight heparin, was recently approved
for use in the United States to prevent deep-vein thrombosis after total hip replacement …

Introduction: We compared the efficacy and safety of standard heparin to that of low
molecular weight heparin (Enoxaparin) in 100 hip replacement patients. Materials and …

Consecutive patients undergoing total hip replacement in 43 centres were randomly
assigned to receive blindly either enoxaparin (40 mg) or tinzaparin (4,500 anti-Factor IU Xa) …

Four clinical studies were conducted in the United States and Canada to compare the
efficacy and safety of Enoxaparin, a low molecular weight heparin, with low dose …

The effectiveness and safety of warfarin were compared with those of a low-molecular-
weight heparin (dalteparin) for the prevention of deep-vein thrombosis after total hip …

Background The risk of venous thromboembolism in patients undergoing total hip
replacement is known to be high. However, the optimal duration of prophylaxis with …